Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | ISO | Sfxn2 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SFXN2 mRNA] | CTD | PMID:31150632 | 1,1-dichloroethene | decreases expression | ISO | Sfxn2 (Mus musculus) | 6480464 | vinylidene chloride results in decreased expression of SFXN2 mRNA | CTD | PMID:26682919 | 1,2-dimethylhydrazine | increases expression | ISO | Sfxn2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of SFXN2 mRNA | CTD | PMID:22206623 | 14-Deoxy-11,12-didehydroandrographolide | decreases expression | EXP | | 6480464 | 14-deoxy-11 and 12-didehydroandrographolide results in decreased expression of SFXN2 mRNA | CTD | PMID:22101062 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of SFXN2 mRNA | CTD | PMID:16474171 more ... | 17beta-estradiol | decreases expression | ISO | Sfxn2 (Rattus norvegicus) | 6480464 | Estradiol results in decreased expression of SFXN2 mRNA | CTD | PMID:32145629 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of SFXN2 mRNA | CTD | PMID:30165855 | 17beta-estradiol | multiple interactions | ISO | Sfxn2 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of SFXN2 mRNA | CTD | PMID:26496021 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Sfxn2 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | Sfxn2 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:27291303 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Sfxn2 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Sfxn2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SFXN2 mRNA | CTD | PMID:19770486 and PMID:28213091 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Sfxn2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SFXN2 gene] | CTD | PMID:28213091 | 3-chloropropane-1,2-diol | increases expression | ISO | Sfxn2 (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in increased expression of SFXN2 mRNA | CTD | PMID:28522335 | 4,4'-diaminodiphenylmethane | decreases expression | ISO | Sfxn2 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of SFXN2 mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | decreases expression | ISO | Sfxn2 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of SFXN2 mRNA | CTD | PMID:37611474 | 6-propyl-2-thiouracil | decreases expression | ISO | Sfxn2 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of SFXN2 mRNA | CTD | PMID:30047161 | acetamide | decreases expression | ISO | Sfxn2 (Rattus norvegicus) | 6480464 | acetamide results in decreased expression of SFXN2 mRNA | CTD | PMID:31881176 | acrylamide | increases expression | ISO | Sfxn2 (Rattus norvegicus) | 6480464 | Acrylamide results in increased expression of SFXN2 mRNA | CTD | PMID:28959563 | afimoxifene | multiple interactions | EXP | | 6480464 | afimoxifene inhibits the reaction [Estrogens results in increased expression of SFXN2 mRNA] | CTD | PMID:21233418 | aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of SFXN2 protein | CTD | PMID:20106945 | aflatoxin B1 | decreases expression | ISO | Sfxn2 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of SFXN2 mRNA | CTD | PMID:19770486 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of SFXN2 mRNA | CTD | PMID:23724009 | amitrole | decreases expression | ISO | Sfxn2 (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of SFXN2 mRNA | CTD | PMID:30047161 | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of SFXN2 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of SFXN2 mRNA | CTD | PMID:33212167 | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of SFXN2 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | decreases expression | ISO | Sfxn2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of SFXN2 mRNA | CTD | PMID:19770486 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of SFXN2 mRNA | CTD | PMID:32234424 | benzo[a]pyrene | multiple interactions | ISO | Sfxn2 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SFXN2 mRNA | CTD | PMID:27858113 | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:26238291 | benzo[b]fluoranthene | multiple interactions | ISO | Sfxn2 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SFXN2 mRNA | CTD | PMID:27858113 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SFXN2 mRNA and bisphenol A results in decreased expression of SFXN2 protein | CTD | PMID:29275510 and PMID:33376534 | bisphenol A | decreases expression | ISO | Sfxn2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of SFXN2 mRNA | CTD | PMID:32156529 | bisphenol A | increases expression | ISO | Sfxn2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of SFXN2 mRNA | CTD | PMID:34947998 | bisphenol A | decreases expression | ISO | Sfxn2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of SFXN2 mRNA | CTD | PMID:25181051 and PMID:32145629 | bisphenol A | multiple interactions | ISO | Sfxn2 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of SFXN2 mRNA and [bisphenol A co-treated with Testosterone] results in increased expression of SFXN2 mRNA | CTD | PMID:26496021 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SFXN2 mRNA | CTD | PMID:16474171 | bisphenol F | increases expression | ISO | Sfxn2 (Mus musculus) | 6480464 | bisphenol F results in increased expression of SFXN2 mRNA | CTD | PMID:37611474 | chrysene | multiple interactions | ISO | Sfxn2 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SFXN2 mRNA | CTD | PMID:27858113 | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of SFXN2 mRNA | CTD | PMID:27392435 | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of SFXN2 mRNA | CTD | PMID:27392435 | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of SFXN2 mRNA | CTD | PMID:19549813 | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 | coumestrol | increases expression | EXP | | 6480464 | Coumestrol results in increased expression of SFXN2 mRNA | CTD | PMID:19167446 | cyclosporin A | decreases expression | ISO | Sfxn2 (Mus musculus) | 6480464 | Cyclosporine results in decreased expression of SFXN2 mRNA | CTD | PMID:19770486 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of SFXN2 mRNA | CTD | PMID:27989131 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of SFXN2 mRNA | CTD | PMID:20106945 and PMID:25562108 | decabromodiphenyl ether | decreases expression | ISO | Sfxn2 (Rattus norvegicus) | 6480464 | decabromobiphenyl ether results in decreased expression of SFXN2 mRNA | CTD | PMID:23640034 | decabromodiphenyl ether | increases expression | ISO | Sfxn2 (Rattus norvegicus) | 6480464 | decabromobiphenyl ether results in increased expression of SFXN2 mRNA | CTD | PMID:23640034 | dicrotophos | increases expression | EXP | | 6480464 | dicrotophos results in increased expression of SFXN2 mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFXN2 mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of SFXN2 mRNA | CTD | PMID:29803840 | Enterolactone | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SFXN2 mRNA | CTD | PMID:19167446 | epoxiconazole | decreases expression | ISO | Sfxn2 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of SFXN2 mRNA | CTD | PMID:35436446 | fenthion | increases expression | ISO | Sfxn2 (Mus musculus) | 6480464 | Fenthion results in increased expression of SFXN2 mRNA | CTD | PMID:34813904 | folic acid | decreases expression | ISO | Sfxn2 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of SFXN2 mRNA | CTD | PMID:25629700 | genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of SFXN2 mRNA | CTD | PMID:16474171 | hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of SFXN2 mRNA | CTD | PMID:18951874 | hydroquinone O-beta-D-glucopyranoside | decreases expression | EXP | | 6480464 | Arbutin results in decreased expression of SFXN2 mRNA | CTD | PMID:17103032 | lamivudine | multiple interactions | ISO | Sfxn2 (Mus musculus) | 6480464 | [Zidovudine co-treated with Lamivudine] results in increased expression of SFXN2 mRNA | CTD | PMID:18313992 | leflunomide | decreases expression | EXP | | 6480464 | leflunomide results in decreased expression of SFXN2 mRNA | CTD | PMID:28988120 and PMID:29427785 | maneb | multiple interactions | ISO | Sfxn2 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in increased expression of SFXN2 mRNA | CTD | PMID:36117858 | methimazole | decreases expression | ISO | Sfxn2 (Rattus norvegicus) | 6480464 | Methimazole results in decreased expression of SFXN2 mRNA | CTD | PMID:30047161 | miconazole | decreases expression | ISO | Sfxn2 (Mus musculus) | 6480464 | Miconazole results in decreased expression of SFXN2 mRNA | CTD | PMID:27462272 | N-methyl-4-phenylpyridinium | increases expression | ISO | Sfxn2 (Rattus norvegicus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of SFXN2 mRNA | CTD | PMID:28801915 | N-Nitrosopyrrolidine | decreases expression | EXP | | 6480464 | N-Nitrosopyrrolidine results in decreased expression of SFXN2 mRNA | CTD | PMID:32234424 | nickel sulfate | decreases expression | EXP | | 6480464 | nickel sulfate results in decreased expression of SFXN2 mRNA | CTD | PMID:22714537 | niclosamide | decreases expression | EXP | | 6480464 | Niclosamide results in decreased expression of SFXN2 mRNA | CTD | PMID:36318118 | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of SFXN2 mRNA | CTD | PMID:35430440 | paracetamol | affects expression | ISO | Sfxn2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of SFXN2 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | ISO | Sfxn2 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of SFXN2 mRNA | CTD | PMID:33387578 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of SFXN2 mRNA | CTD | PMID:25704631 and PMID:26690555 | paraquat | decreases expression | ISO | Sfxn2 (Rattus norvegicus) | 6480464 | Paraquat results in decreased expression of SFXN2 mRNA | CTD | PMID:32680482 | paraquat | multiple interactions | ISO | Sfxn2 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in increased expression of SFXN2 mRNA | CTD | PMID:36117858 | PCB138 | multiple interactions | ISO | Sfxn2 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | phenobarbital | affects expression | ISO | Sfxn2 (Mus musculus) | 6480464 | Phenobarbital affects the expression of SFXN2 mRNA | CTD | PMID:23091169 | propiconazole | decreases expression | ISO | Sfxn2 (Mus musculus) | 6480464 | propiconazole results in decreased expression of SFXN2 mRNA | CTD | PMID:21278054 | resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of SFXN2 mRNA | CTD | PMID:19167446 | rotenone | increases expression | ISO | Sfxn2 (Rattus norvegicus) | 6480464 | Rotenone results in increased expression of SFXN2 mRNA | CTD | PMID:28374803 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFXN2 mRNA | CTD | PMID:27188386 | silver atom | increases expression | ISO | Sfxn2 (Mus musculus) | 6480464 | Silver results in increased expression of SFXN2 mRNA | CTD | PMID:27131904 | silver(0) | increases expression | ISO | Sfxn2 (Mus musculus) | 6480464 | Silver results in increased expression of SFXN2 mRNA | CTD | PMID:27131904 | sotorasib | multiple interactions | EXP | | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SFXN2 mRNA | CTD | PMID:36139627 | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of SFXN2 mRNA | CTD | PMID:31533062 | testosterone | multiple interactions | ISO | Sfxn2 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Testosterone] results in increased expression of SFXN2 mRNA | CTD | PMID:26496021 | testosterone | decreases expression | ISO | Sfxn2 (Mus musculus) | 6480464 | Testosterone deficiency results in decreased expression of SFXN2 mRNA | CTD | PMID:33848595 | tetrachloromethane | multiple interactions | ISO | Sfxn2 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SFXN2 mRNA] | CTD | PMID:31150632 | tetrachloromethane | decreases expression | ISO | Sfxn2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of SFXN2 mRNA | CTD | PMID:31919559 | tetrachloromethane | decreases expression | ISO | Sfxn2 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of SFXN2 mRNA | CTD | PMID:31150632 | tetraphene | multiple interactions | ISO | Sfxn2 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SFXN2 mRNA | CTD | PMID:27858113 | thapsigargin | decreases expression | EXP | | 6480464 | Thapsigargin results in decreased expression of SFXN2 mRNA | CTD | PMID:22378314 | thioacetamide | decreases expression | ISO | Sfxn2 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of SFXN2 mRNA | CTD | PMID:23411599 and PMID:34492290 | trametinib | multiple interactions | EXP | | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SFXN2 mRNA | CTD | PMID:36139627 | triadimefon | decreases expression | ISO | Sfxn2 (Rattus norvegicus) | 6480464 | triadimefon results in decreased expression of SFXN2 mRNA | CTD | PMID:30047161 | tunicamycin | decreases expression | EXP | | 6480464 | Tunicamycin results in decreased expression of SFXN2 mRNA | CTD | PMID:22378314 | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of SFXN2 mRNA | CTD | PMID:28818685 | valproic acid | decreases methylation | EXP | | 6480464 | Valproic Acid results in decreased methylation of SFXN2 gene | CTD | PMID:29154799 | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFXN2 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of SFXN2 mRNA | CTD | PMID:23179753 more ... | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of SFXN2 mRNA | CTD | PMID:25979313 | vancomycin | increases expression | ISO | Sfxn2 (Mus musculus) | 6480464 | Vancomycin results in increased expression of SFXN2 mRNA | CTD | PMID:18930951 | zidovudine | multiple interactions | ISO | Sfxn2 (Mus musculus) | 6480464 | [Zidovudine co-treated with Lamivudine] results in increased expression of SFXN2 mRNA | CTD | PMID:18313992 | |